Vladimir P. Torchilin, PhD, DSc, University Distinguished Professor and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, School of Pharmacy, Bouve College of Health Sciences, Northeastern University

Title to be announced

Marina A.Dobrovolskaia, Ph.D., MBA, PMP, Senior Principal Scientist, Head, Immunology Section, Nanotechnology Characterization Lab, Leidos Biomedical Research Inc, Frederick National Laboratory for Cancer Research

Achievements, Disappointments, and Lessons Learned from Immunotoxicity Studies of Nanotechnology-Formulated Complex Drugs

Daryl Drummond, PhD, Head of Research, Merrimack Pharmaceuticals

Clinical Translation of Non-targeted and Antibody-targeted Nanotherapeutics into the Clinic: Opportunities and Challenges

Konstantin Konstantinov, PhD, Senior Vice President Manufacturing and Process Sciences, Codiak BioSciences

exosomes as therapeutics - Title to be announced

Staci Sabnis, MS, Senior Scientist, Moderna Therapeutics

nucleic acid therapeutics - Title to be announced

Johan Skog, PhD, Chief Scientific Officer, Exosome Diagnostics

Exosome Enrichment Enables Tissue Specific Liquid Biopsy Analysis

Kristy Wood, PhD, Senior Director, Intellia Therapeutics

CRISPR therapies - Title to be announced

Ken Bernstein, Senior Scientist, Nanomedicine Development and Manufacturing, Pfizer

manufacturing and scale-up - Title to be announced